Corbus Pharmaceuticals Holdings, Inc. Interest Expense, Lessee, Assets under Capital Lease
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Interest Expense, Lessee, Assets under Capital Lease of $712 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseLesseeAssetsUnderCapitalLease · last filed 2018-03-12
- Corbus Pharmaceuticals Holdings, Inc. interest expense, lessee, assets under capital lease for fiscal 2017 was $712.00, a 44.63% decline from fiscal 2016.
- Corbus Pharmaceuticals Holdings, Inc. interest expense, lessee, assets under capital lease for fiscal 2016 was $1.29K.
- Corbus Pharmaceuticals Holdings, Inc. interest expense, lessee, assets under capital lease for fiscal 2015 was $0.00.
| Period end | Interest Expense, Lessee, Assets under Capital Lease 12 month |
|---|---|
| 2017-12-31 | $712.00 10-K · filed 2018-03-12 |
| 2016-12-31 | $1.29K 10-K · filed 2018-03-12 |
| 2015-12-31 | $0.00 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |